The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of 3 different dosing regimens of
enoxaparin in achieving adequate antithrombotic aFXa levels in critically ill patients.
The relationship between appearance of DVT and antithrombotic aFXa levels will also be
assessed and risk factors associated with inadequate aFXa levels under standard enoxaparin
dosages will be searched for.